Sexually Transmitted Diseases  >  Gonorrhea  >  Antibiotic-Resistant Gonorrhea  >  Resources and References

Resources and References

Resources

STD Surveillance Reports

• 2005 STD Surveillance Report

• 2004 STD Surveillance Report

• 2003 STD Surveillance Report

• 2002 STD Surveillance Report

• 2001 STD Surveillance Report

• 2000 STD Surveillance Report

Fact Sheets and General Information

• Gonorrhea - CDC Fact Sheet.    (en Español)

• Antimicrobial Resistance in Neisseria gonorrheae - CDC Fact Sheet.

• Quinolones and the Clinical Laboratory - information from CDC.

• Multi-Drug Resistant Neisseria gonorrhoeae with Decreased Susceptibility to Cefixime, Hawaii, 2001 (webcast and slides)

• Control of Neisseria gonorrhoeae Infection in the United States - Report of an External Consultants' Meeting. 9 April 2003
• B88 document- Neisseria gonorrhoeae reference strains for antimicrobial susceptibility testing 

• Antimicrobial Resistance (all diseases)

• Public Health Action Plan to Combat Antimicrobial Resistance- United States

References

MMWRs

• Increases in Fluoroquinolone-Resistant Neisseria gonorrhoeae Among Men Who Have Sex with Men --- United States, 2003, and Revised Recommendations for Gonorrhea Treatment, 2004 - MMWR. 30 April 2004

• Notice to Readers: Discontinuation of Cefixime Tablets 22 November 2002

• Notice to Readers: Recall of LCx® Neisseria gonorrhoeae Assay and Implications for Laboratory Testing for N. gonorrhoeae and Chlamydia trachomatis - MMWR. 19 August 2002

• Increases in Fluoroquinolone-Resistant Neisseria gonorrhoeae --- Hawaii and California, 2001 22 November 2002  (Print Version )

• Notice to Readers: Update on Spectinomycin Availability in the United States - MMWR. 3 August 2001
• Alternatives to Spectinomycin for the Treatment of Neisseria Gonorrhoeae 8 June 2001

• Fluoroquinolone-Resistance in Neisseria gonorrhoeae, Hawaii, 1999, and Decreased Susceptibility to Azithromycin in N. gonorrhoeae, Missouri, 1999 22 September 2000 (Print Version )

• Gonorrhea --- United States, 1998. 23 June 2000

• Increases in Unsafe Sex and Rectal Gonorrhea Among Men Who Have Sex with Men - San Francisco, California, 1994-1997. 29 January 1999 (Print Version )

• Fluoroquinolone-Resistant Neisseria gonorrhoeae -- San Diego, California, 1997. 29 May 1998

• Gonorrhea Among Men Who Have Sex with Men -- Selected Sexually Transmitted Diseases Clinics, 1993-1996. 26 September 1997 (Print Version )

• Fluoroquinolone Resistance in Neisseria gonorrhoeae- Colorado and Washington, 1995. 20 October 1995 (Print Version )

• Sentinel Surveillance for Antimicrobial Resistance in Neisseria gonorrhoeae- United States, 1988-1991. 13 August 1993 (Print Version )

• Antibiotic-Resistant Strains of Neisseria gonorrhoeae: Policy Guidelines for Detection, Management, and Control. (Sept 11, 1987) Vol 36/ No.5S: 1-18.

• Sentinel Surveillance for Antimicrobial Resistance in Clinical Isolates of Neisseria gonorrhoeae. 11 September 1987

GISP Publications and Abstracts

• Bauer HM, Hannah P, Moore D, Wolfe J, Knapp J, Trees D, Wang S, Bolan G.  Molecular epidemiology of quinolone-resistant Neisseria gonoeehoeae in California, 2000-2002.  [Abstract 283]  15th Biennial Congress of the International Society for Sexually Transmitted Diseases Research, Ottawa, Canada, July 27-30, 2003.

• Conner SM, Wang SA, Weinstock HS.  Ciprofloxacin resistant gonorrhea within the continental United States, 1991-2000 [Abstract].  2002 National STD Prevention Conference, San Diego, CA.  March 4-7, 2002.  

• Fox KK, del Rio C, Holmes KK, Hook EW, Judson FN, Knapp JS, Procop GW, Wang SA, Whittington WL, Levine WC.  Gonorrhea in the HIV Era: A Reversal in Trends Among Men Who Have Sex With Men.  American Journal of Public Health.  2001;91:959-964. 

• Fox KK, Knapp JS, Homes KK, Hook EW, Judson FN, Thompson SE, Washington JA, Whittington WL.  Antimicrobial Resistance in Neisseria gonorrhoeae in the United States, 1988-1994: The Emergence of Decreased Susceptibility to the Fluoroquinolones.  Journal of Infectious Disease.  1997;175:1396-1403.

• Iverson CJ, Wang SA, Ohye R, Lee V, Domen H, Neal S, Trees D, Whiticar P, Effler P.  Emergence of a possible endemic focus of ciprofloxacin-resistant Neisseria gonorrhoeae in Hawaii. [Abstract]  Second International Conference on Emerging Infectious Diseases, Atlanta, GA.  July 16-19, 2000.

• Johnson SR, Sandul AL, Parekh M, Wang SA, Knapp JS, Trees DL.  Mutations causing in vitro resistance to azithromycin in Neisseria gonorrhoeae.  International Journal of Antimicrobial Agents.  2003;21:414-419. 

• Katz AR, Lee MV, Ohye RG, Whiticar PM, Effler PV.  Ciprofloxacin resistance in Neisseria gonorrhoeae: trends in Hawaii, 1997-2002.  The Lancet.  2003;362(9382):495.    

• Knapp JS, Fox KK, Trees DL, Whittington WL.  Fluoroquinolone Resistance in Neisseria gonorrhoeae.  Emerging Infectious Diseases.  1997;3:33-39.

• Mark KE, Bauer HM, Gunn RA, Wang SA, Knapp JS, Moore DS, Weismuller P, Klausner JD, De Augustine N, Bolan G, and the California Resistance Working Group.  Increase in fluoroquinolone-resistant Neisseria gonorrhoea- California, 2001 [Abstract 21].  40th Annual Meeting of the Infectious Diseases Society of America, Chicago, Illinois, October 24-27, 2002.

• McLean CA, Wang SA, Hoff G, Dennis L, Neal S, Knapp J, Markowitz L, Levine WC.  Emergence of Neisseria gonorrhoeae with decreased susceptibility to azithromycin associated with commercial sex in Kansas City, Missouri, 1999. [Abstract 543]  38th Annual Meeting of the Infectious Diseases Society of America, New Orleans, LA.  September 7-10, 2000.

• McLean CA, Wang SA, Hoff GL, Dennis LY, Trees DL, Knapp JS, Markowitz LE, Levine WC.  The emergence of Neisseria gonorrhoeae with decreased susceptibility to azithromycin in Kansas City, Missouri, 1999-2000.  Sexually Transmitted Diseases 2004;31:73-78. 

• Newman LM, Wang, SA, Ohye RG, Lee MV, Weinstock, HS.  The epidemiology of fluoroquinolone-resistant Neisseria gonorrhoeae in Hawaii, 2001.  Clinical Infectious Diseases 2004;38:649-654.

• Newman LM, Wang SA, Weinstock HS.  Emergence of ciprofloxacin-resistant Neisseria gonorrhoea prevalence and risk factors for infection- United States, 1998-2000 [Abstract 651].  40th Annual Meeting of the Infectious Diseases Society of America, Chicago, Illinois, October 24-27, 2002.

• Roy K, Wang S, Meltzer M.  Identifying the optimal diagnostic and treatment strategy for gonorrhea in a time of increasing ciprofloxacin-resistance [Abstract].  2002 National Foundation for Infectious Diseases Conference on Antimicrobial Resistance, Bethesda, Maryland, June 27-29, 2002.

• Schwarcz SK, Zenilman JM, Schnell D, Knapp JS, Hook EW, Thompson S, Judson FN, Holmes KK.  National Surveillance of Antimicrobial Resistance in Neisseria gonorrhoeae.  JAMA.  1990;264:1413-1417.   

• Wang SA.  The continuing saga of gonococcal resistance :  current epidemiology and challenges.  2002 National Foundation for Infectious Diseases Conference on Antimicrobial Resistance, Bethesda, Maryland, June 29, 2002.

• Wang SA, Harvey AB, Conner SM, Weinstock HS.  Gonococcal susceptibility and epidemiological trends: data from the Gonococcal Isolate Surveillance Project, United States, 2002.  [Abstract 284]  15th Biennial Congress of the International Society for Sexually Transmitted Diseases Research, Ottawa, Canada, July 27-30, 2003. 

• Wang SA, Harvey AB, Conner SM, Weinstock HS, and the Gonococcal Isolate Surveillance Project Investigators.  Trends in gonococcal susceptibility and epidemiology in the United States for 2002 identified through the Gonococcal Isolate Surveillance Project.  [Abstract 924].  41st Annual Meeting of the Infectious Diseases Society of America, San Diego, California, October 9-10, 2003. 

• Wang SA, Harvey AB, Weinstock HS.  Antimicrobial susceptibilities of Neisseria gonorrhoeae in the United States [Abstract 401].  Thirteenth International Pathogenic Neisseria Conference , Olso, Norway, September 1-6, 2002.

• Wang SA, Lee MV, Iverson CJ, O'Connor N, Ohye RG, Hale JA, Knapp JS, Effler PV, Weinstock HS. Multi-drug resistant Neisseria gonorrhoeae with decreased susceptibility to cefixime, Hawaii 2001. [Abstract] International Conference on Emerging Infectious Diseases, Atlanta, Georgia.  March 25, 2002.

• Wang SA, Lee MVC, Norman O'Connor N, Iverson CJ, Ohye RG, Whiticar PM, Hale JA, Trees DL, Knapp JS, Effler PV, Weinstock HS.  Multi-drug resistant Neisseria gonorrhoeae with decreased susceptibility to cefixime, Hawaii, 2001.  Clinical Infectious Diseases 2003;37:849-52

• Wang SA, Lee MVC, O'Connor N, Iverson CJ, Ohye RG, Whiticar PM, Hale JA, Trees DL, Knapp JS, Effler PV, and Weinstock HS. Multidrug-resistant Neisseria gonorrhoeae with decreased susceptibility to cefixime -- Hawaii, 2001. Clinical Infectious Diseases 2003;37:849-52

Other Relevant Publications and Abstracts

• Akasaka S, Muratani T, Kobayashi T, Yamada Y, Inatomi H, Takahashi K, Matsumoto T.  Gonococcal urethritis and cervicitis caused by CZRNG (cefozopran-resistant Neisseria gonorrhoeae)- clinical failure cases treated with expanded spectrum cephems, fluoroquinolones and minocycline [Abstract].  Thirteenth International Pathogenic Neisseria Conference, Norwegian Institute of Public Health, Olso, Norway.  September 1-6, 2002.

• Bala M, Ray K, Kumari S.  Alarming increase in ciprofloxacin- and penicillin-resistant Neisseria gonorrhoeae isolates in New Delhi, India.  Sexually Transmitted Diseases.  2003 Jun; 30(6):523-5.

• Dan M, Poch F, Sheinberg B.  High prevalence of high-level ciprofloxacin resistance in Neisseria gonorrhoeae in Tel Aviv, Israel: Correlation with response to therapy.  Antimicrobial Agents and Chemotherapy.  2002 Jun;46(6):1671-3.

• Dan M, Poch F, Shpitz D, and Sheinberg B.  High-level ciprofloxacin resistance in Neisseria gonorrhoeae: First report from Israel. Emerging Infectious Diseases.  2001;7(1):1-2.

• Etkind P, Ratelle S, and George H.  International travel and sexually transmitted disease.  Emerging Infectious Diseases. [Letter]  2003;9(12):654-1656.  

• Fenton KA, Ison C, Johnson AP, Rudd E, Soltani M, Martin I, Nichols T, Livermore DM.  Ciprofloxacin resistance in Neisseria gonorrhoeae in England and Wales in 2002.  The Lancet.  2003;361:1867-1869.

• Forsyth A, Moyes A, Young H.  Increased resistance in gonococci isolated from Scotland.  The Lancet.  2000;356:1984-85.

• Goulet V, Sednaoui P, Laporte A, Billy C, Desenclos JC. The number of gonococcal infections identified by the RENAGO network is increasing.  Eurosurveillance Monthly.  2000 January;5(1):2-5.   

• Hoffman, S.  The laboratory surveillance system of Chlamydia trachomatis and Neisseria gonorrhoeae infections in Denmark.  Eurosurveillance Monthly.  2001 May;6(5):86-90.

• Mavroidi A, Tzouvelekis LS, Tassios PT, Flemetakis A, Daniilidou M, and Tzelepi E. Characterization of Neisseria gonorrhoeae Strains with Decreased Susceptibility to Fluoroquinolones Isolated in Greece from 1996 to 1999.  Journal of Clinical Microbiology.  2000;38:3489-3491

• Muratani T, Kobayashi T, Yamada Y, Akasaka S, Inatomi H, Takahashi K, Matsumoto T.  Prevalence of super multi-drug resistant Neisseria gonorrhoeae CZRNG (cefozopran-resistant N. gonorrhoeae) in Japan.  Thirteenth International Pathogenic Neisseria Conference, Norwegian Institute of Public Health, Olso, Norway.  September 1-6, 2002.

• Rudd E and Fenton K.  Large increase in ciprofloxacin resistant gonorrhoea in England and Wales.  Eurosurveillance Weekly.  2003 April;7(16).

• Young H.  Epidemiology and treatment outcome of infection with antibiotic resistant strains of Neisseria gonorrhoeae in Scotland.  Communicable Disease and Public Health.  1999 Sept;2(3):198-202.